Yayın:
Atherogenic index of plasma (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events

dc.contributor.authorOnat, Altan
dc.contributor.authorCan, Guenay
dc.contributor.authorKaya, Hasan
dc.contributor.authorHergenc, Guelay
dc.date.accessioned2026-06-27T12:52:48Z
dc.date.issued2010
dc.description.abstractOBJECTIVES: To determine the association of atherogenic index of plasma (ALP), the logarithm of molar ratio of triglyceridemia to high-density lipoprotein cholesterol (TG/HDL-cholesterol) with cardiometabolic disorders was investigated in a sample of the Turkish population. METHODS: A total of 2676 middle-aged adults were prospectively evaluated with a clinical examination and laboratory tests during 7.8 years' follow-up. RESULTS: AIP was significantly associated in multiple linear regression analyses with greater apolipoprotein B and lower low-density lipoprotein (LDL)-cholesterol levels, reflecting the presence of smaller LDL particle size. Whereas in men insulin levels, obesity, and nonHDL-cholesterol were major determinants, C-reactive protein (CRP) was the strongest determinant of AIP among women, independent of body mass index. Top quartiles of AIP predicted significantly age-adjusted incident coronary heart disease (CHD) in both sexes, more strongly in women, in whom quartile 3 also was a predictor with a greater than 2-fold relative risk. Associations remained significant after adjustment for CRP and traditional risk factors. AIP significantly predicted diabetes and high blood pressure in both sexes after adjustment for age and CRP. With regard to incident high blood pressure, the risk ratio in men was attenuated when body mass index also was adjusted. CONCLUSIONS: High AIP, a surrogate of small LDL particle size, reflects obesity and hyperinsulinemia in men and high CRP status in women. It predicts CHD independently, type 2 diabetes mediated by obesity in men and in women, high blood pressure, metabolic syndrome, and CHD potentially mediated by involvement in a proinflammatory status reflected by CRP. (C) 2010 National Lipid Association. All rights reserved.en
dc.description.sponsorshipTurkish Society of Cardiology
dc.description.sponsorshipTurkish Ministry of Health
dc.description.urihttps://doi.org/10.1016/j.jacl.2010.02.005
dc.identifier.doi10.1016/j.jacl.2010.02.005
dc.identifier.endpage98
dc.identifier.issn1933-2874
dc.identifier.issue2
dc.identifier.pubmed21122635
dc.identifier.startpage89
dc.identifier.urihttps://hdl.handle.net/20.500.14981/47788
dc.identifier.volume4
dc.identifier.wos000276748100004
dc.language.isoeng
dc.publisherELSEVIER SCIENCE INC
dc.relation.ispartofJOURNAL OF CLINICAL LIPIDOLOGY
dc.subjectAtherogenic dyslipidemia
dc.subjectCoronary heart disease
dc.subjectDiabetes mellitus
dc.subjectInflammation
dc.subjectMetabolic syndrome
dc.subjectESTERIFICATION RATE
dc.subjectABDOMINAL OBESITY
dc.subjectRISK
dc.subjectRATIO
dc.subjectDISEASE
dc.subjectPOPULATION
dc.subjectWOMEN
dc.subjectMEN
dc.subjectDEFINITION
dc.subjectPharmacology & Pharmacy
dc.titleAtherogenic index of plasma (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar